. | Unadjusted OR . | 95% CI . | Adjusted OR . | 95% CI . | P . |
---|---|---|---|---|---|
Age (per 5 years) | 0.74 | 0.69–0.79 | 0.77 | 0.72–0.84 | <0.001 |
Female sex | 0.60 | 0.43–0.83 | 0.78 | 0.55–1.10 | 0.16 |
Heart failure | 0.73 | 0.51–1.04 | 1.01 | 0.69–1.47 | 0.97 |
Cerebrovascular disease | 0.73 | 0.51–1.04 | 1.08 | 0.74–1.57 | 0.70 |
Fracture | 0.64 | 0.38–1.10 | 0.83 | 0.48–1.43 | 0.50 |
UTI | 0.52 | 0.36–0.75 | 0.69 | 0.47–1.03 | 0.07 |
ACE inhibitor/ARB | 1.95 | 1.25–3.04 | 1.76 | 1.12–2.77 | 0.01 |
eGFR (per 10 mL/min/1.73 m2) | 1.32 | 1.21–1.45 | 1.21 | 1.09–1.33 | <0.001 |
UACR (per 100 mg/g Cr) | 0.99 | 0.97–1.00 | 0.98 | 0.97–1.00 | 0.02 |
A1C | 1.16 | 1.09–1.24 | 1.09 | 1.01–1.17 | 0.03 |
. | Unadjusted OR . | 95% CI . | Adjusted OR . | 95% CI . | P . |
---|---|---|---|---|---|
Age (per 5 years) | 0.74 | 0.69–0.79 | 0.77 | 0.72–0.84 | <0.001 |
Female sex | 0.60 | 0.43–0.83 | 0.78 | 0.55–1.10 | 0.16 |
Heart failure | 0.73 | 0.51–1.04 | 1.01 | 0.69–1.47 | 0.97 |
Cerebrovascular disease | 0.73 | 0.51–1.04 | 1.08 | 0.74–1.57 | 0.70 |
Fracture | 0.64 | 0.38–1.10 | 0.83 | 0.48–1.43 | 0.50 |
UTI | 0.52 | 0.36–0.75 | 0.69 | 0.47–1.03 | 0.07 |
ACE inhibitor/ARB | 1.95 | 1.25–3.04 | 1.76 | 1.12–2.77 | 0.01 |
eGFR (per 10 mL/min/1.73 m2) | 1.32 | 1.21–1.45 | 1.21 | 1.09–1.33 | <0.001 |
UACR (per 100 mg/g Cr) | 0.99 | 0.97–1.00 | 0.98 | 0.97–1.00 | 0.02 |
A1C | 1.16 | 1.09–1.24 | 1.09 | 1.01–1.17 | 0.03 |
Unadjusted ORs are shown for Table 1 variables with univariate P values <0.2. Those variables were included in the multivariable model, and those with adjusted ORs with P values <0.05 are shown in bold.